See more : Asia Metal Public Company Limited (AMC.BK) Income Statement Analysis – Financial Results
Complete financial analysis of CareMax, Inc. (CMAX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CareMax, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Imaspro Corporation Berhad (7222.KL) Income Statement Analysis – Financial Results
- Sanlien Technology Corp. (5493.TWO) Income Statement Analysis – Financial Results
- Henan Jindan Lactic Acid Technology Co., Ltd (300829.SZ) Income Statement Analysis – Financial Results
- Fortune Real Estate Investment Trust (0778.HK) Income Statement Analysis – Financial Results
- Williston Holding Company, Inc. (WHCA) Income Statement Analysis – Financial Results
CareMax, Inc. (CMAX)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.caremax.com
About CareMax, Inc.
CareMax, Inc. provides medical services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States. As of December 31, 2021, it operated 48 multi-specialty medical care centers in Florida, Tennessee, and New York. The company is headquartered in Miami, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 751.10M | 631.13M | 295.76M | 103.42M | 90.60M | 72.38M |
| Cost of Revenue | 737.20M | 550.83M | 264.31M | 83.42M | 51.62M | 44.16M |
| Gross Profit | 13.90M | 80.30M | 31.45M | 20.00M | 38.98M | 28.22M |
| Gross Profit Ratio | 1.85% | 12.72% | 10.63% | 19.34% | 43.02% | 38.99% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 80.68M | 75.82M | 40.58M | 7.75M | 11.56M | 23.53M |
| Selling & Marketing | 14.27M | 11.76M | 4.96M | 1.07M | 20.85M | 1.21M |
| SG&A | 94.96M | 87.59M | 45.53M | 8.82M | 32.41M | 24.74M |
| Other Expenses | 575.10M | 21.72M | 13.22M | 1.50M | 0.00 | 0.00 |
| Operating Expenses | 670.05M | 109.30M | 58.75M | 10.32M | 32.41M | 24.74M |
| Cost & Expenses | 1.41B | 660.13M | 323.06M | 93.74M | 84.04M | 68.90M |
| Interest Income | 0.00 | 20.24M | 4.49M | 1.66M | 720.40K | 0.00 |
| Interest Expense | 54.43M | 20.24M | 4.49M | 1.66M | 0.00 | 0.00 |
| Depreciation & Amortization | 39.31M | 21.72M | 13.22M | 1.50M | 975.90K | 602.85K |
| EBITDA | -590.46M | -15.38M | 11.19M | 11.18M | 7.54M | 4.09M |
| EBITDA Ratio | -78.61% | -1.07% | -11.80% | 10.81% | 8.32% | 5.65% |
| Operating Income | -656.15M | -29.00M | -27.30M | 9.68M | 6.57M | 3.49M |
| Operating Income Ratio | -87.36% | -4.60% | -9.23% | 9.36% | 7.25% | 4.82% |
| Total Other Income/Expenses | -28.06M | -28.34M | 22.31M | -2.11M | -720.40K | 0.00 |
| Income Before Tax | -684.21M | -57.34M | -6.52M | 7.57M | 5.85M | 3.49M |
| Income Before Tax Ratio | -91.09% | -9.09% | -2.20% | 7.32% | 6.45% | 4.82% |
| Income Tax Expense | -863.00K | -19.54M | 159.00K | 1.63M | -173.19K | 16.47K |
| Net Income | -683.35M | -37.80M | -6.68M | 5.94M | 6.02M | 3.47M |
| Net Income Ratio | -90.98% | -5.99% | -2.26% | 5.75% | 6.64% | 4.79% |
| EPS | -183.30 | -12.49 | -3.90 | 16.42 | 0.00 | 9.54 |
| EPS Diluted | -183.30 | -12.49 | -3.81 | 16.51 | 0.00 | 9.64 |
| Weighted Avg Shares Out | 3.73M | 3.03M | 1.71M | 361.95K | 0.00 | 363.66K |
| Weighted Avg Shares Out (Dil) | 3.73M | 3.03M | 1.75M | 359.87K | 0.00 | 359.87K |
New Strong Sell Stocks for April 1st
New Strong Sell Stocks for March 28th
New Strong Sell Stocks for March 20th
CareMax, Inc. (CMAX) Q4 2023 Earnings Call Transcript
CareMax Reports Fourth Quarter and Full Year 2023 Results
CMAX ALERT: Levi & Korsinsky, LLP Commences an Investigation of CareMax, Inc. (CMAX) f/k/a Deerfield Healthcare Technology Acquisitions Corp. (DFHT)
CareMax Announces 1-for-30 Reverse Stock Split
CareMax, Inc. (CMAX) Q3 2023 Earnings Call Transcript
CareMax Reports Third Quarter 2023 Results
CareMax Schedules Third Quarter 2023 Earnings Conference Call
Source: https://incomestatements.info
Category: Stock Reports